Market
What will be the primary method to control the mutated H5N1 virus by end of 2025?
2
Resolution / Starting Odds
Vaccination • 25%
Quarantine and isolation • 25%
Travel restrictions • 25%
Other • 25%
Official health guidelines and reports from WHO or CDC
Story
Scripps Research Finds H5N1 Bird Flu Mutation Could Enable Human Transmission
Dec 5, 2024, 08:02 PM
Researchers at Scripps Research Institute have discovered that a single mutation in the H5N1 bird flu virus could enhance its ability to bind to human cells, potentially increasing the risk of human-to-human transmission. This finding, published in Science Magazine, underscores the importance of vigilant surveillance of the virus, especially given its spread through U.S. cattle herds. The mutation could make the virus more adept at latching onto human cells, raising concerns about its potential to become a significant public health threat. Three cases of human contamination with H5N1 have already been detected in North America, though the origins of these infections remain unclear.
View original story
Similar markets
Vaccination • 25%
Antiviral medication • 25%
Public health measures (e.g., masks, distancing) • 25%
Other • 25%
Newly developed antiviral drugs • 25%
Existing antiviral drugs • 25%
Other • 25%
Natural compounds • 25%
Vaccination • 25%
Other • 25%
Culling • 25%
Quarantine • 25%
Quarantine • 25%
Public Awareness Campaigns • 25%
Other • 25%
Vaccination • 25%
Culling affected flocks • 25%
Other methods • 25%
Vaccination • 25%
Quarantine and movement restrictions • 25%
Other • 25%
Vaccine distribution • 25%
Increased testing • 25%
Public awareness campaigns • 25%
Increase vaccine stockpile • 25%
Enhance surveillance measures • 25%
Develop new antiviral treatments • 25%
No significant new policy/action • 25%
No vaccine introduced • 33%
Vaccine in development • 33%
Vaccine approved • 34%
No significant measures • 25%
Vaccine development • 25%
Travel advisories • 25%
Quarantine measures • 25%
Other • 25%
Bird-to-human • 25%
Environment-to-human • 25%
Human-to-human • 25%
World Health Organization • 25%
Other • 25%
Scripps Research Institute • 25%
Centers for Disease Control and Prevention • 25%